Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gen-Probe (US) licenses patented tests to Becton Dickinson (US):

This article was originally published in Clinica

Executive Summary

Gen-Probe (US) has granted Becton Dickinson (US) a non-exclusive worldwide right to its patented methods for detecting vaginosis and vaginitis. In exchange for the rights to patent nos 4,851,330 and 5,288,611, Becton will make an upfront payment of an undisclosed sum and pay a royalty on sales of the licensed products. Becton says it will also defend Gen-Probe's patents against further infringement. The patents are "in a disease category that Gen-Probe currently has no plans to enter", says president and CEO Henry Nordhoff.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts